Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

Todd Bedrick Biography and Net Worth

VP of Absci

Mr. Todd Bedrick is the VP of Absci.

How do I contact Todd Bedrick?: The corporate mailing address for Mr. Bedrick and other Absci executives is , , . Absci can also be reached via phone at 360-949-1041 and via email at [email protected]. Learn More on Todd Bedrick's contact information.
Has Todd Bedrick been buying or selling shares of Absci?: Todd Bedrick has not been actively trading shares of Absci over the course of the past ninety days. Most recently, on Thursday, January 20th, Todd Bedrick bought 2,000 shares of Absci stock. The stock was acquired at an average cost of $7.50 per share, with a total value of $15,000.00. Learn More on Todd Bedrick's trading history.
Who are Absci's active insiders?: Absci's insider roster includes Todd Bedrick (VP), Sarah Korman (General Counsel), Sean Mcclain (Insider), and Karen Mcginnis (Director). Learn More on Absci's active insiders.
Are insiders buying or selling shares of Absci?: In the last year, Absci insiders bought shares 1 times. They purchased a total of 222,222 shares worth more than $999,999.00. The most recent insider tranaction occured on March, 1st when Director Redmile Group, Llc bought 222,222 shares worth more than $999,999.00. Insiders at Absci own 11.6% of the company. Learn More about insider trades at Absci.
Information on this page was last updated on 3/1/2024.

Todd Bedrick Insider Trading History at Absci

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
1/20/2022	Buy	2,000	$7.50	$15,000.00
7/26/2021	Buy	1,000	$16.00	$16,000.00

Todd Bedrick Buying and Selling Activity at Absci

Absci Company Overview

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Today's Range

Now: $4.89

$4.84

$5.04

50 Day Range

MA: $5.19

$4.30

$6.59

2 Week Range

Now: $4.89

$1.11

$6.72

Volume

556,326 shs

Average Volume

1,526,406 shs

Market Capitalization

$551.54 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.36